ArticleAdvanced materials (Deerfield Beach, Fla.)2026
Digital Microneedles for Multiplexed Transdermal Sensing via Fluorescent QR Codes.
Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Real-time biochemical sensing is essential for precision medicine, yet current wearable and transdermal biosensors suffer from signal drift, calibration demands, and limited multiplexing capabilities in vivo. Here, we introduce digital fluorescent microneedles that translate analyte concentrations into scannable QR codes via threshold-activated probes. Each microneedle functions as a fluorescent binary switch, turning "on" only above a defined analyte threshold, thereby eliminating the need for calibration and enhancing robustness against tissue heterogeneity and environmental noise. The microneedles feature a biodegradable, mechanically optimized "baby-bottle" design that enables reliable skin penetration and controlled tip detachment. Central to this concept is the rational engineering of fluorescent probes with discrete activation thresholds, which-when embedded in microneedles-produce stepwise readouts spanning physiopathological ranges of pH (4.5-8.5) and glucose (1-10 mM). By tuning probe loading, we achieve reproducible threshold activation, enabling fully digital, multiplexed detection of pH and glucose in skin with classification accuracies of 93% and 85%. This digital encoding concept is broadly extensible to diverse probes and biomarkers, providing a scalable route to calibration-free, multiplexed biosensing in vivo. The QR-based output delivers a direct, quantitative representation of biochemical information, facilitating decentralized diagnostics and integration into digital health workflows. Together, these advances establish digital microneedles as a versatile and clinically relevant platform for transdermal biosensing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.